Avanos Medical, Inc. (AVNS)

Avanos Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	701.2	687.8	673.3	684.1	587
Revenue Growth (YoY)	1.95%	2.15%	-1.58%	16.54%	-17.88%
Cost of Revenue	347.3	306.5	293.6	289.9	287.8
Gross Profit	353.9	381.3	379.7	394.2	299.2
Selling, General & Admin	315.6	318.5	335	326.5	285.3
Research & Development	23.3	26.2	27.2	29.2	30.6
Other Operating Expenses	77.4	440.6	-13.3	-3	-
Total Operating Expenses	416.3	785.3	348.9	352.7	315.9
Operating Income	-61.6	-396.2	4.2	35.5	-39
Interest Income	3.2	5.1	2.9	1.2	0.2
Interest Expense	-7.8	-12.2	-15	-10	-3.3
Other Non-Operating Income (Expense)	-	-	-	-	-22.3
Total Non-Operating Income (Expense)	-4.6	-7.1	-12.1	-8.8	-25.4
Pretax Income	-66.2	-403.3	-7.9	26.7	-42.1
Provision for Income Taxes	6.7	-17	2	5.2	-11.2
Net Income	72.9	392.1	61.8	-50.5	-6.3
Earnings From Discontinued Operations	-	-5.8	-51.9	29	37.2
Net Income to Common	72.9	392.1	61.8	-50.5	-6.3
Net Income Growth	-81.41%	534.47%	-	-	-
Shares Outstanding (Basic)	46	46	47	47	48
Shares Outstanding (Diluted)	46	46	47	47	49
Shares Change (YoY)	0.65%	-1.29%	-1.48%	-2.67%	1.67%
EPS (Basic)	-1.57	-8.53	-1.32	1.08	-0.64
EPS (Diluted)	-1.57	-8.53	-1.32	1.07	-0.64
Free Cash Flow	43.1	82.9	14.6	71.6	66.3
Free Cash Flow Growth	-48.01%	467.81%	-79.61%	7.99%	-
Free Cash Flow Per Share	0.93	1.80	0.31	1.51	1.36
Gross Margin	50.47%	55.44%	56.39%	57.62%	50.97%
Operating Margin	-8.78%	-57.60%	0.62%	5.19%	-6.64%
Profit Margin	-10.40%	-56.16%	-1.47%	3.14%	-5.26%
FCF Margin	6.15%	12.05%	2.17%	10.47%	11.29%
EBITDA	-22.7	-350.7	50.3	83.2	-0.7
EBITDA Margin	-3.24%	-50.99%	7.47%	12.16%	-0.12%
EBIT	-61.6	-396.2	4.2	35.5	-39
EBIT Margin	-8.78%	-57.60%	0.62%	5.19%	-6.64%
Effective Tax Rate	-10.12%	4.22%	-25.32%	19.48%	26.60%

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q